GPC1 is upregulated in pancreatic cancer, esophageal cancer, and prostate cancer, and it promotes the proliferation and movement of esophageal cancer cells by PTEN/Akt/β-catenin pathway [24,25,26]. This evidence concerns the gene PTEN and prostate carcinoma.